CarboplatinPaclitaxelAntineoplastic Combined Chemotherapy ProtocolsOvarian NeoplasmsDrug Administration SchedulePlatinumLung NeoplasmsEtoposideCisplatinAntineoplastic AgentsIfosfamideThrombocytopeniaCarcinoma, Non-Small-Cell LungTreatment OutcomeOrganoplatinum CompoundsArea Under CurveCombined Modality TherapyInfusions, IntravenousRetinal NeoplasmsFallopian Tube NeoplasmsThiotepaMaximum Tolerated DoseDisease-Free SurvivalLeukopeniaRetinoblastomaNeutropeniaDeoxycytidineDose-Response Relationship, DrugHematologic DiseasesNeoplasm StagingSurvival AnalysisSurvival RateAmifostineCarcinoma, Small CellTopotecanPeritoneal NeoplasmsSeminomaDrug EvaluationTaxoidsIsocoumarinsDrug HypersensitivityGerminomaNeoplasmsTesticular NeoplasmsNeoplasm Recurrence, LocalCyclophosphamideVinblastineGuanineAntineoplastic Agents, PhytogenicNeoplasms, Germ Cell and EmbryonalNauseaGlutamatesCarcinomaMesnaRemission InductionNeoplasms, Glandular and EpithelialAntibodies, Monoclonal, HumanizedDoxorubicinNeoplasms, Unknown PrimarySalvage TherapyFeasibility StudiesVomitingDrug Resistance, NeoplasmPlatinum CompoundsAlopeciaFolic Acid TransportersGenital Neoplasms, FemaleTriethylenephosphoramideUrologic NeoplasmsChemotherapy, AdjuvantDrug SynergismTransplantation, AutologousHearing Loss, High-FrequencyBone Marrow DiseasesBrain NeoplasmsHyperthermia, InducedNeoplasm Metastasis